Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Emory University · NCT04342429

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
30
US sites recruiting
1
Study start
March 19, 2020
Record last updated
September 17, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

Being studied: Proton-beam Therapy for Small Cell Lung Cancer

Conditions: Small-cell Lung Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Pathologically confirmed small cell lung cancer, limited or extensive stage.
  • Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
  • Age 18 or greater

Exclusion Criteria

  • Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
  • Pregnancy

Recruiting US locations

  • Winship Cancer Institute

    Atlanta, GA 30322

    Site contact: Kristin Higgins, MD · 404-778-0603 · kristin.higgins@emory.edu

Study contacts (from the official record)

  • Kristin Higgins, MD · 404-778-0603 · kristin.higgins@emory.edu
  • Allyson Anderson · 404-251-2854 · allyson.anderson@emory.edu
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for… (NCT04342429) | Bored Studies